Xihui Xu, PharmD, PhD

Director
QurAlis Corporation
Cambridge, Massachusetts, United States

Presentation(s):

• Biomarkers for CNS Toxicity—From Bench to Bedside (S07)

  Tuesday, November 19, 2024
  9:00 AM - 12:00 PM CT

• Welcome (S07-1)

  Tuesday, November 19, 2024
  9:00 AM - 9:05 AM CT

• Advances and Challenges in Oligonucleotide and mRNA Therapeutics: New Strategies and Regulatory Perspectives (S12)

  Tuesday, November 19, 2024
  2:00 PM - 5:00 PM CT

• Welcome (S12-1)

  Tuesday, November 19, 2024
  2:00 PM - 2:05 PM CT